ARL6IP5 composite agent for preventing, improving or treating anticancer agent-resistant ovarian cancer

摘要

The present invention relates to a composition for preventing, improving or treating anticancer drug-resistant ovarian cancer containing ARL6IP5 protein as an active ingredient. is excellent, and the anticancer effect is remarkably enhanced when used together with cisplatin or olaparib can